期刊文献+

气相色谱法测定注射用去水卫矛醇的含量及有关物质 被引量:4

Determination of Dianhydrogalactitol for Injection and Related Substances by GC
下载PDF
导出
摘要 目的:建立注射用卫矛醇含量及有关物质的气相色谱法。方法:采用Agilent DB-1(30 m×0.53 mm,1.5μm);程序升温:起始温度为100℃,维持3 min,以10℃·min^(-1)升至200℃,维持5 min;进样口温度为250℃,检测器F1D温度为250℃;载气为氮气,流速为5 ml·min^(-1)。结果:去水卫矛醇与其相邻杂质峰能完全分离,去水卫矛醇在0.010 05~1.005 mg·ml^(-1)浓度范围内线性关系良好(r=0.999 1),平均回收率为101.1%(RSD=1.12%,n=9)。结论:本方法操作简单,精密度好,结果准确可靠,可用于该制剂的质量控制。 Objective: To establish a GC method for determination of assay and related substances of dianhydrogalaetitol for injection. Method: Using a GC method with a capillary column, which temperature rose by program. The initial temperature was 100 ℃ , maintained for 3 rain, raised to 200 ℃ with a rate of 10 ℃ · min^- 1, then maintained for 5 min. The temperature of injection port was 250 ℃ and the temperature of FID detection was 250 ℃. The carrier gas was nitrogen and the flow rate was 5 ml. min^-1. Result: The data showed that this method could clearly separate dianhydrogalactitol peak from its nearby impurity peaks, with a better linear range of 0. 010 05-1. 005 mg· ml^- 1 (r = 0. 999 1 ) , and the average recovery range of 101.1% (RSD = 1.12% , n = 9 ). Conclusion: This method is simple, accurate and liable,it can be used for quality control of this preparation.
出处 《中国药师》 CAS 2011年第9期1306-1307,共2页 China Pharmacist
关键词 注射用去水卫矛醇 含量测定 有关物质 气相色谱法 Dianhydrogalactitol for injection Assay Related substances GC
  • 相关文献

参考文献4

二级参考文献6

共引文献6

同被引文献23

  • 1赖祥进,曹林枝,周瑛,蓝秀万,廖志红,周素芳.二乙酰去水卫矛醇联合p53基因转染对肝癌细胞生长的影响[J].中国癌症杂志,2004,14(4):309-312. 被引量:5
  • 2CHIUTEN D F, ROZENCWEIG M, Von HOFF D, et al. Clinical trials with the hexitol derivatives in the U. S. [J]. Cancer, 1981,47:442 -451.
  • 3BACHA J A, BROWN D M, GARNER W A. Veteri- nary use of dianhydrogalactitol, diacetyldianhydroga- lactitol, and dibromodulcitol to treat malignancies: 2013169600[P]. 2013 - 11 - 14.
  • 4ELSON L A, JARMAN M, ROSS W C J. Toxicity, haematological effects and anti-tumour activity ofepoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol [J]. Eur J Cancer,1968(4) :617 -625.
  • 5JARMAN M, ROSS W C J. The formation of epo- xides from substituted hexitols[J]. Carbohyd Res, 1969(9) :139 - 147.
  • 6BROWN D M. Method of synthesis of substituted hexitols such as dianhydrogalactitol: 2012024368 [P]. 2012 -02 -23.
  • 7BROWN D M. Method of synthesis of substituted hexitols such as dianhydrogalactitol: 20140155638 [P]. 2014 - 06 - 05.
  • 8国家药典委员会.国家药品标准[s].化学药品地标升国标.第15册.北京:中国医药科技出版社,2003:77.
  • 9国家药典委员会.国家药品标准[s].化学药品地标升国标.第8册.北京:中国医药科技出版社,2002:112.
  • 10于小波,沈文斌,相秉仁.定量核磁共振技术及其在药学领域中的应用进展[J].药学进展,2010,34(1):17-23. 被引量:57

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部